ICER 2023: Circular targets remain out of reach The Netherlands aims to have a fully circular economy by 2050 and halve its use of raw materials by 2030. In recent years, however, little progress has been made in either regard.
Urgent need for more research into environmental effects of microplastics Additional solutions are urgently needed to limit emissions of microplastics into the environment. Growing quantities of microplastics (particles of 5 mm or less) are entering our living environment every day.
Circular economy: plastics recycling from end-of-life vehicles could be four times higher At present, 85% of plastics from end-of-life vehicles is still incinerated. Only 15% of plastics is reused as a raw material. A survey conducted by RIVM has revealed possibilities to expand recovery of these plastics fourfold by 2030.
Proposed European PFAS ban officially submitted The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
State Secretary Blokhuis: boys will also be vaccinated against HPV virus The vaccine against the HPV human papillomavirus virus will also become available for boys.
A guide for the safe reuse of diaper and incontinence materials RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.
CleaR delivers framework for risk assessment of substances of concern in the recycling process For a successful circular economy, it is essential to improve the conditions in which materials and products are recycled once they have reached the end of their life cycle.
Affirmation of collaboration between Public Health England and RIVM On Thursday 11 April 2019, RIVM welcomed a delegation from Public Health England (PHE). Chief Executive Duncan Selbie of PHE headed the delegation.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.